IP Library Granted Patent US 7,129,392
Granted Patent B2
US 7,129,392 · App. 10/835,516 · Granted Oct 31, 2006

Materials and methods for increasing isoprenoid production in cells

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,129,392
App. No.
10/835,516
Granted
Oct 31, 2006
Kind
B2
Abstract

Disclosed are the uses of specific genes of the mevalonate and isoprenoid biosynthetic pathways, and of inactive gene sites (the pseudogene) to (1) enhance biosynthesis of isopentenyl diphosphate, dimethylallyl diphosphate and isoprenoid pathway derived products in the plastids of transgenic plants and microalgae, (2) create novel antibiotic resistant transgenic plants and microalgae, and (3) create a novel selection system and/or targeting sites for mediating the insertion of genetic material into plant and microalgae plastids. The specific polynucleotides to be used, solely or in any combination thereof, are publicly available from GeneBank and contain open reading frames having sequences that upon expression will produce active proteins with the following enzyme activities: (a) acetoacetyl CoA thiolase (EC 2.3.1.9), (b) 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) synthase (EC 4.1.3.5), (c) HMG-CoA reductase (EC 1.1.1.34), (d) mevalonate kinase (EC 2.7.1.36), (e) phosphomevalonate kinase (EC 2.7.4.2), (f) mevalonate diphosphate decarboxylase (EC 4.1.1.33), (g) isopentenyl diphosphate (IPP) isomerase (EC 5.3.3.2), and (h) phytoene synthase (EC 2.5.1.32).

Claims (18)

1. A method for providing transformed cells having increased isoprenoid production as compared to non-transformed cells, comprising the steps of:

providing an isolated polynucleotide comprising polynucleotide sequences encoding the enzymes of the complete mevalonate pathway;

providing a plurality of target cells, said target cells selected from the group consisting of bacteria, microalgae, and plant cells;

introducing said isolated polynucleotide into said target cells;

selecting target cells which have been transformed with said polynucleotide; and

growing said transformed cells under conditions whereby additional generations of descendant transformed cells are produced, said transformed cells exhibiting increased isoprenoid production as compared to non-transformed cells of the same type.

2. The method according to claim 1 , wherein said isolated polynucleotide further comprises a polynucleotide sequence encoding IPP isomerase.

3. The method of claim 1 , wherein said target cells are plant cells, and wherein the resulting transformed plant cells are tansplastomic or have been transformed to express plastid-targeted enzymes of the mevalonate pathway.

4. The method of claim 1 , wherein said target cells are microalgae.

5. The method of claim 3 , further comprising the step of regenerating said transformed plant cells into a transformed plant, wherein said transformed plant comprises tissue exhibiting increased isoprenoid production as compared to a non-transformed plant of the same type.

6. The method according to claim 1 , wherein said polynucleotide comprises the polynucleotide sequence of SEQ ID NO: 59.

7. The method of claim 1 , wherein said target cells are bacteria.

8. The method of claim 2 , wherein said target cells are bacteria.

9. The method of claim 2 , wherein said target cells are plant cells, and wherein the resulting transformed plant cells are transplastomic or have been transformed to express plastid-targeted enzymes of the mevalonate pathway.

10. The method of claim 2 , wherein said target cells are microalgae.

11. The method of claim 9 , further comprising the step of regenerating said transformed cells into a transformed plant, wherein said transformed plant comprises tissue exhibiting increased isoprenoid production as compared to a non-transformed plant of the same type.

12. The method of claim 7 , wherein the bacteria is E. coli.

13. The method of claim 8 , wherein the bacteria is E. coli.

Assignments (7)
SECURITY INTEREST Recorded Aug 17, 2023
From: AMYRIS, INC.; AMYRIS CLEAN BEAUTY, INC.; AMYRIS FUELS, LLC; AB TECHNOLOGIES LLC; APRINNOVA, LLC; AMYRIS-OLINKA, LLC; ONDA BEAUTY INC.; UPLAND 1 LLC; AMYRIS ECO-FAB LLC; CLEAN BEAUTY 4U HOLDINGS, LLC; AMYRIS CLEAN BEAUTY LATAM LTDA; INTERFACES INDUSTRIA E COMERCIA DE COSMETICOS LTDA; AMYRIS BIOTECHNOLOGIA DO BRASIL LTDA; AMYRIS EUROPE TRADING B.V. (NETHERLANDS); AMYRIS BIO PRODCUTS PORTUGAL, UNIPESSOAL, LDA; BEAUTY LABS INTERNATIONAL LIMITED; AMYRIS UK TRADING LIMITED
To: EUAGORE, LLC
Reel/Frame 064619/0778 →
SECURITY INTEREST Recorded Aug 3, 2023
From: AMYRIS CLEAN BEAUTY, INC.; AMYRIS FUELS, LLC; AB TECHNOLOGIES LLC; AMYRIS, INC.
To: MUIRISC, LLC
Reel/Frame 064492/0518 →
RELEASE OF SECURITY INTEREST Recorded Feb 14, 2023
From: NAXYRIS S.A.
To: AMYRIS, INC.
Reel/Frame 062760/0753 →
SECURITY INTEREST Recorded Aug 16, 2019
From: AMYRIS, INC.
To: NAXYRIS S.A.
Reel/Frame 050081/0106 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 19, 2016
From: DANISCO US INC.
To: THE GOODYEAR TIRE & RUBBER COMPANY
Reel/Frame 040066/0867 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 5, 2008
From: HAHN, FREDERICK M.
To: DANISCO US INC.
Reel/Frame 021478/0706 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 28, 2007
From: KUEHNLE, ADELHEID R.
To: KUEHNLE AGROSYSTEMS COMPANY LLC
Reel/Frame 018939/0096 →